Encephalitis: From Molecular Pathophysiology to Therapy
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 96
Special Issue Editors
Interests: pathophysiology of encephalitis; cellular and molecular interactions in neuroinflammation
Interests: diagnosis and therapy of infectious and autoimmune encephalitis
Special Issue Information
Dear Colleagues,
Encephalitis remains a significant global health concern due to its complex etiology, severe clinical manifestations, and potential long-term consequences for survivors. Caused by infectious agents such as viruses, bacteria, and parasites, alongside autoimmune and idiopathic mechanisms, encephalitis presents unique challenges for diagnosis, treatment, and management. This is especially important where the spreading of infectious agents and their vectors are becoming significant due to global warming, good diagnostic approaches and therapy.
Despite advances in neuroimaging, molecular diagnostics, and therapeutic approaches, significant gaps persist in our understanding of the pathophysiology, epidemiology, and clinical outcomes of encephalitis.
This Special Issue aims to provide a comprehensive exploration of the multifaceted nature of encephalitis. The topics to be covered include an improved understanding of molecular and cellular interactions in neuroinflammation, improved diagnostics, and novel insights into therapy.
We invite submissions of original research articles, systemic reviews, meta-analyses, and case reports addressing issues related to infectious, autoimmune, and idiopathic encephalitis.
Dr. Anna Tröscher
Dr. Judith Wagner
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious encephalitis
- autoimmune encephalitis
- neuroinflammation
- pathophysiology
- diagnostics
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
